LINC01605

Across TCGA pan-cancer cohorts, LINC01605 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC01605 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01605 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01605 expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

KIRC, MESO, and UVM are the cancer types where LINC01605 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.525	0.707	<.001	178	view →
MESO	OS	Median	All	0.290	0.495	.001	57	view →
UVM	OS	Quartile	All	0.378	1.000	.002	56	view →
KIRP	OS	Median	All	0.829	0.938	.002	25	view →
PAAD	OS	Tertile	All	0.387	0.621	.004	24	view →
CESC	DFS	Quartile	III,IV	0.238	0.859	.003	22	view →
READ	OS	Quartile	II,III,IV	0.952	0.649	.010	16	view →
TGCT	DFS	Tertile	All	0.691	0.907	.005	16	view →
SKCM	OS	Median	IV	0.764	0.241	.014	15	view →
GBM	OS	Tertile	All	0.343	0.493	.008	14	view →
BLCA	OS	Median	All	0.330	0.558	.021	13	view →
OV	DFS	Tertile	All	0.498	0.591	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC01605–KIRC (DFS)

Open the KIRC breakdown →